WHO/UNICEF Joint Reporting Process

WHO/UNICEF Joint Reporting Process
Name	WHO/UNICEF Joint Reporting Process
Formation	1998
Type	International health collaboration
Headquarters	Geneva
Parent organization	World Health Organization; United Nations Children's Fund

Contents

WHO/UNICEF Joint Reporting Process

The WHO/UNICEF Joint Reporting Process is a collaborative surveillance and monitoring mechanism administered by the World Health Organization and the United Nations Children's Fund to collect, validate, and disseminate data on immunization, vaccine-preventable diseases, and related child health indicators. The process informs global initiatives such as the Global Vaccine Action Plan, the Sustainable Development Goals, the Gavi, the Vaccine Alliance, and the Global Polio Eradication Initiative by providing standardized country-level reporting used by agencies like the World Bank, the United Nations, and regional entities such as the Pan American Health Organization.

Overview

The Joint Reporting Process aggregates country-submitted information on immunization coverage, vaccine stock, and campaign activities into harmonized datasets for stakeholders including the World Health Organization, the United Nations Children's Fund, the Gavi, the Vaccine Alliance, the Global Polio Eradication Initiative, and technical advisory groups such as the Strategic Advisory Group of Experts on Immunization. It interfaces with global monitoring frameworks like the Sustainable Development Goals and complements surveillance networks exemplified by the Global Influenza Surveillance and Response System, the Integrated Disease Surveillance and Response, and regional observatories including the European Centre for Disease Prevention and Control.

The initiative emerged from earlier cooperative reporting efforts among the World Health Organization, the United Nations Children's Fund, and partners including the United Nations Development Programme and the World Bank to harmonize disparate immunization datasets during the late 1990s and early 2000s. Its evolution was influenced by major global health milestones such as the launch of the Global Polio Eradication Initiative, the endorsement of the Global Vaccine Action Plan at the World Health Assembly, and funding and governance inputs from entities like Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation. Subsequent methodological refinements reflected lessons from outbreaks documented in Ebola virus epidemic in West Africa, Zika virus outbreak, and regional immunization challenges in contexts like South Sudan and Sierra Leone.

The process aims to produce reliable country-level estimates for immunization coverage, document vaccine-preventable disease incidence, and track programmatic indicators for partners including Gavi, the Vaccine Alliance, the Global Polio Eradication Initiative, and national ministries in countries from India to Brazil and Nigeria. It supports accountability to multilateral frameworks such as the Sustainable Development Goals and reporting commitments to the World Health Assembly, while informing technical guidance from advisory bodies like the Strategic Advisory Group of Experts on Immunization and funders like the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Data are collected via standardized annual questionnaires sent to national authorities, triangulated with household surveys such as the Demographic and Health Surveys and the Multiple Indicator Cluster Surveys, administrative records from ministries in countries including Ethiopia and Pakistan, and surveillance outputs from networks like the Global Polio Laboratory Network. The methodology integrates population denominators from sources such as the United Nations Population Division and employs statistical adjustments similar to those used by the Institute for Health Metrics and Evaluation and modeling approaches discussed at forums like the World Health Assembly and meetings of the Strategic Advisory Group of Experts on Immunization.

Core indicators include routine immunization coverage for antigens like DTP vaccine and measles vaccine, vaccine stock and cold chain measures akin to metrics used by the Expanded Programme on Immunization, and campaign performance indicators similar to those tracked by the Global Polio Eradication Initiative. Definitions align with standards promulgated by the World Health Organization, measurement conventions from the United Nations Children's Fund, and internationally recognized survey protocols such as those of the Demographic and Health Surveys and the Multiple Indicator Cluster Surveys.

Governance is joint between the World Health Organization and the United Nations Children's Fund, with technical input from advisory bodies including the Strategic Advisory Group of Experts on Immunization and collaborations with partners such as Gavi, the Vaccine Alliance, the Global Polio Eradication Initiative, the World Bank, and philanthropic actors like the Bill & Melinda Gates Foundation. National ministries in countries like Kenya, Bangladesh, and Mexico are primary respondents, while regional offices such as the Regional Office for South-East Asia of the WHO and the Regional Office for Africa of the WHO support validation and capacity-building.

Validation processes combine administrative reconciliation, cross-checks with household surveys including the Demographic and Health Surveys and the Multiple Indicator Cluster Surveys, and technical review by experts from institutions such as the London School of Hygiene & Tropical Medicine and the Johns Hopkins Bloomberg School of Public Health. Accountability mechanisms feed into global oversight by the World Health Assembly and funding conditionalities from partners like Gavi, the Vaccine Alliance and the Global Polio Eradication Initiative, and are informed by audit practices similar to those in multilateral institutions such as the World Bank.

Outputs are published in annual datasets and reports used by policymakers in national ministries, donors including the World Bank and Gavi, the Vaccine Alliance, researchers at institutions like the Institute for Health Metrics and Evaluation and Harvard T.H. Chan School of Public Health, and multilateral bodies such as the United Nations for monitoring Sustainable Development Goals progress. The process has shaped policy decisions on immunization financing, campaign targeting in contexts like Nigeria and Pakistan, and strategic guidance adopted at forums such as the World Health Assembly and technical meetings of the Strategic Advisory Group of Experts on Immunization.